Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Clinical results of XEN gel stent implant in minimally invasive combined glaucoma and cataract surgery

Search Title by author or title

Session Details

Session Title: Presented Poster Session: FLACS & Others

Venue: Poster Village: Pod 1

First Author: : A.De Gregorio ITALY

Co Author(s): :    L. Russo   M. Montali   G. Stevan   S. Morselli     

Abstract Details


To verify the efficacy in intraocular pressure (IOP) reduction and safety of the smallest gel stent (XEN 45 Gel Stent) microincisional glaucoma surgery (MIGS) combined with microincisional cataract surgery (MICS).


San Bassiano Hospital, Bassano del Grappa, Italy


Non-randomized prospective clinical study. Forty-one eyes of 33 patients with open-angle glaucoma (OAG) underwent a XEN 45 gel stent implantation combined with MICS. Treatment outcomes analyzed included IOP, medication use, intra e postoperative complications. At the end of the follow-up we evaluated the complete success, defined as a postoperative IOP ≥ 6 mmHg and ≤ 17 mmHg without glaucoma medications and the qualified success defined as a post-operative IOP ≥ 6 mmHg and ≤ 17 mmHg , with glaucoma medications.


The mean preoperative IOP was 22.5 ± 3.7 mmHg on 2.5 ± 0.9 medication classes. After 12 months the mean postoperative IOP was 13.1 ± 2.4 mmHg (mean IOP reduction of 41.82%) with a mean of 0.4 ± 0.8 medication classes (P < 0.05 for IOP and medications). The complete success rate was achieved in 80.4% and a qualified success in 97.5%. No major intra and postoperative complications during the first year of follow-up.


This study demonstrated that the smaller diameter XEN 45 gel implant is statistically effective in reducing IOP and medications in glaucoma patients with a low rate of complications.

Financial Disclosure:


Back to previous